TargetMol

TargetMol logo

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain,professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening. We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Company Website

Product Listing

β-Lactamase-IN-4 5 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-4 (WO2013149121A1, compound 708) is a potent β-lactamase inhibitor. It serves as a valuable tool in the investigation of bacterial infections.

More Information Supplier Page

β-Lactamase-IN-5 5 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-5, a β-lactamase inhibitor isolated from compound 720, as described in patent WO2013149121A1, holds significant potential for studying bacterial infections.

More Information Supplier Page

β-Lactamase-IN-7 5 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-7 (compound 14) effectively inhibit Klebsiella pneumoniae that is a potent inhibitor of VIM-Type metallo-β-lactamase with Ki values of 1.26 μM and 0.54 μM for VIM-1 and VIM-4, respectively [1].

More Information Supplier Page

β-Lactamase-IN-7 50 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-7 (compound 14) effectively inhibit Klebsiella pneumoniae that is a potent inhibitor of VIM-Type metallo-β-lactamase with Ki values of 1.26 μM and 0.54 μM for VIM-1 and VIM-4, respectively [1].

More Information Supplier Page

β-Lactamase-IN-7 100 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-7 (compound 14) effectively inhibit Klebsiella pneumoniae that is a potent inhibitor of VIM-Type metallo-β-lactamase with Ki values of 1.26 μM and 0.54 μM for VIM-1 and VIM-4, respectively [1].

More Information Supplier Page

β-Lactamase-IN-8 5 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-8 (compound 20) is a potent and oral bioavailable broad-spectrum cyclic boronate β-lactamase inhibitor that can be used for researching antibacteria [1].

More Information Supplier Page

β-Lactamase-IN-8 50 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-8 (compound 20) is a potent and oral bioavailable broad-spectrum cyclic boronate β-lactamase inhibitor that can be used for researching antibacteria [1].

More Information Supplier Page

β-Lactamase-IN-8 100 mg  | Purity Not Available

TargetMol

β-Lactamase-IN-8 (compound 20) is a potent and oral bioavailable broad-spectrum cyclic boronate β-lactamase inhibitor that can be used for researching antibacteria [1].

More Information Supplier Page

β-Lapachone 25 mg  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Lapachone 200 mg  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Lapachone 1 mL  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Lapachone 5 mg  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Lapachone 500 mg  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Lapachone 100 mg  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Lapachone 10 mg  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Lapachone 50 mg  | 99.86%

TargetMol

β-Lapachone (ARQ-501) is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.

More Information Supplier Page

β-Methyl L-aspartate hydrochloride 5 g  | Purity Not Available

TargetMol

β-Methyl L-aspartate hydrochloride is an aspartic acid derivative that is used in the synthesis of a variety of compounds and has been implicated in body immunity and metabolism.

More Information Supplier Page

β-Methylcrotonyl coenzyme A lithium 5 mg  | Purity Not Available

TargetMol

β-Methylcrotonyl coenzyme A lithium is an intermediate in leucine metabolism and can be used as a substrate to study the specificity and kinetics of β-methylcrotonyl coenzyme A carboxylase (MCCase) [1] .

More Information Supplier Page

β-Methylcrotonyl coenzyme A lithium 50 mg  | Purity Not Available

TargetMol

β-Methylcrotonyl coenzyme A lithium is an intermediate in leucine metabolism and can be used as a substrate to study the specificity and kinetics of β-methylcrotonyl coenzyme A carboxylase (MCCase) [1] .

More Information Supplier Page

β-N-Acetyl-D-hexosaminidase-IN-1 5 mg  | Purity Not Available

TargetMol

β-N-Acetyl-D-hexosaminidase-IN-1 is a newly discovered chemical compound that acts as an inhibitor for β-N-acetyl-D-hexosaminidase. It exhibits a Ki value of 3.72 μM, indicating its potency in inhibiting the enzyme’s activity.

More Information Supplier Page

β-N-Acetyl-D-hexosaminidase-IN-1 50 mg  | Purity Not Available

TargetMol

β-N-Acetyl-D-hexosaminidase-IN-1 is a newly discovered chemical compound that acts as an inhibitor for β-N-acetyl-D-hexosaminidase. It exhibits a Ki value of 3.72 μM, indicating its potency in inhibiting the enzyme’s activity.

More Information Supplier Page

β-N-Acetyl-D-hexosaminidase-IN-1 100 mg  | Purity Not Available

TargetMol

β-N-Acetyl-D-hexosaminidase-IN-1 is a newly discovered chemical compound that acts as an inhibitor for β-N-acetyl-D-hexosaminidase. It exhibits a Ki value of 3.72 μM, indicating its potency in inhibiting the enzyme’s activity.

More Information Supplier Page

β-N-Acetylhexosaminidase 5 mg  | Purity Not Available

TargetMol

β-N-Acetylhexosaminidase is an exoglycosidase that catalyzes the hydrolysis of terminal non-reducing β-N-acetylgalactosamine and glucosamine residues in oligosaccharides for epigenetic applications [1] .

More Information Supplier Page

β-N-Acetylhexosaminidase 50 mg  | Purity Not Available

TargetMol

β-N-Acetylhexosaminidase is an exoglycosidase that catalyzes the hydrolysis of terminal non-reducing β-N-acetylgalactosamine and glucosamine residues in oligosaccharides for epigenetic applications [1] .

More Information Supplier Page

β-N-methylamino-L-alanine hydrochloride 1 mL  | 95.00%

TargetMol

β-N-methylamino-L-alanine hydrochloride (L-BMAA hydrochloride) is a neurotoxin produced by cyanobacteria. L-BMAA hydrochloride could cause amyotrophic lateral sclerosis (ALS) and possibly other neurodegenerative diseases.

More Information Supplier Page

β-N-methylamino-L-alanine hydrochloride 10 mg  | 95.00%

TargetMol

β-N-methylamino-L-alanine hydrochloride (L-BMAA hydrochloride) is a neurotoxin produced by cyanobacteria. L-BMAA hydrochloride could cause amyotrophic lateral sclerosis (ALS) and possibly other neurodegenerative diseases.

More Information Supplier Page

β-N-methylamino-L-alanine hydrochloride 25 mg  | 95.00%

TargetMol

β-N-methylamino-L-alanine hydrochloride (L-BMAA hydrochloride) is a neurotoxin produced by cyanobacteria. L-BMAA hydrochloride could cause amyotrophic lateral sclerosis (ALS) and possibly other neurodegenerative diseases.

More Information Supplier Page

β-N-methylamino-L-alanine hydrochloride 50 mg  | 95.00%

TargetMol

β-N-methylamino-L-alanine hydrochloride (L-BMAA hydrochloride) is a neurotoxin produced by cyanobacteria. L-BMAA hydrochloride could cause amyotrophic lateral sclerosis (ALS) and possibly other neurodegenerative diseases.

More Information Supplier Page